Have £1,000 to invest? These 2 FTSE 100 dividend stocks could help you to retire early

Royston Wild identifies two FTSE 100 (INDEXFTSE: UKX) income shares that could make you a fortune.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A negative verdict on its blockbuster merger from one of Britain’s biggest banks has caused Standard Life Aberdeen’s (LSE: SLA) share price to plummet since the turn of the year.

Its market value has shrunk 30% since then, Lloyds Banking Group’s decision to cancel a £109bn asset management contract in February setting the tone. The move forced investors to seriously reconsider the implications of last summer’s Standard Life-Aberdeen Asset Management tie-up, and Lloyds’ further decision to sell its 3.3% stake in the group in June has hardly improved sentiment either.

It is quite possible that the share price rout could be extended when interim results are released on Tuesday. Most commentators are anticipating a scary update, with UBS for one expecting the asset manager to report outflows of £20bn between January and June.

However, it could also be argued that Standard Life Aberdeen’s ultra-low valuation — a forward P/E ratio of 12.2 times — compared with those of its peers more than prices in the possibility of bad trading news.

In actual fact, I reckon this represents an attractive jumping-in point for long-term investors. I am convinced that once the scale benefits of last summer’s mega-merger become apparent, the asset manager should rise again.

Indeed, City analysts are expecting the Footsie business to snap back into profits expansion on the back of the tie-up next year. And this bright outlook supports predictions that Standard Life Aberdeen will keep its progressive dividend policy ticking along. Last year’s 21.3p per share reward is expected to advance to 22.3p this year and again to 23.5p in 2019, figures that create monster yields of 7.3% and 7.7% respectively.

Flying high

The yields over at International Consolidated Airlines Group (LSE: IAG) may lack the bludgeoning power of those of Standard Life Aberdeen, but I believe the business still has what it takes to create stunning shareholder returns in the years ahead.

Last time I covered the stock in June I paid tribute to the efforts IAG is making to expand its presence in the low-cost airline segment both organically and through game-changing M&A. And the benefits of these twin drives were borne out in latest traffic statistics, the British Airways owner announcing that passenger numbers (as measured in revenue passenger kilometres) rose 9.1% year-on-year in June.

Also since I last wrote about IAG, the business launched its shorthaul Austrian subsidiary under the banner of its budget brand LEVEL, which will operate flights to 14 European destinations from its base in Vienna.

It’s not surprising that City analysts are expecting the FTSE 100 flyer to remain in earnings growth for the next couple of years at least, and this lays the bedrock for predictions of additional dividend expansion too — 2017’s reward of 27 euro cents per share is expected to move to 29 cents this year and to 32 cents in 2019.

These estimates create tasty yields of 3.8% and 4.2% respectively. When combined with IAG’s rock-bottom  forward P/E ratio of 6.8 times, I reckon the aviation colossus is a terrific buy right now.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Lloyds Banking Group and Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »